These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17476163)

  • 21. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Misleading about insulin administration to patients with diabetes].
    Johansen OE; Birkeland KI
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2247; author reply 2247. PubMed ID: 16138161
    [No Abstract]   [Full Text] [Related]  

  • 23. Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
    Yeap BB
    Aust Fam Physician; 2007 Jul; 36(7):549-53. PubMed ID: 17619673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
    Meneghini L
    Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.
    Currie CJ; Evans M; Poole CD
    Diabetes Obes Metab; 2008 Jan; 10(1):94-5. PubMed ID: 18095951
    [No Abstract]   [Full Text] [Related]  

  • 26. Redefining insulin therapy in type 2 diabetes mellitus.
    Rosenstock J
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):21-9. PubMed ID: 19667676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy for NIDDM: has its time arrived?
    Menke J
    S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874
    [No Abstract]   [Full Text] [Related]  

  • 28. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S; Lamine S; Lamine F; Trabelsi N; Aouididi F; Zouaoui C; Mami FB; Achour A
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuation of oral medications when insulin is initiated.
    Neumiller JJ; Setter SM
    South Med J; 2010 Jan; 103(1):7-8. PubMed ID: 19996859
    [No Abstract]   [Full Text] [Related]  

  • 31. The continuation of oral medications with the initiation of insulin therapy in type 2 diabetes: a review of the evidence.
    McFarland MS; Knight TN; Brown A; Thomas J
    South Med J; 2010 Jan; 103(1):58-65. PubMed ID: 19996858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Misleading about type 2 diabetes and insulin].
    Meland E
    Tidsskr Nor Laegeforen; 2005 Dec; 125(24):3519-20; author reply 3520. PubMed ID: 16357910
    [No Abstract]   [Full Text] [Related]  

  • 33. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin requirement after one year of insulin therapy in type 2 diabetic patients dependent on fasting C-peptide.
    Biesenbach G; Bodlaj G; Pieringer H; Raml A
    Neth J Med; 2008 Jun; 66(6):259-60. PubMed ID: 18689911
    [No Abstract]   [Full Text] [Related]  

  • 35. Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes.
    Rave K; Heise T; Pfützner A; Boss AH
    Diabetes Care; 2007 Sep; 30(9):2307-8. PubMed ID: 17586744
    [No Abstract]   [Full Text] [Related]  

  • 36. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Years in the making: inhaled insulin has finally arrived.
    Strain J
    S D Med; 2006 Jul; 59(7):301-2. PubMed ID: 16895053
    [No Abstract]   [Full Text] [Related]  

  • 38. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH; Nattrass M; Pieber TR
    Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 40. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.